Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.220
+0.040 (3.39%)
At close: Mar 20, 2026, 4:00 PM EDT
1.190
-0.030 (-2.46%)
After-hours: Mar 20, 2026, 7:10 PM EDT
Phio Pharmaceuticals Employees
Phio Pharmaceuticals had 6 employees as of December 31, 2025. The number of employees increased by 1 or 20.00% compared to the previous year.
Employees
6
Change (1Y)
1
Growth (1Y)
20.00%
Revenue / Employee
n/a
Profits / Employee
-$1,449,667
Market Cap
14.17M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 6 | 1 | 20.00% | 6 | 0 |
| Dec 31, 2024 | 5 | -4 | -44.44% | 5 | 0 |
| Dec 31, 2023 | 9 | -1 | -10.00% | 8 | 1 |
| Dec 31, 2022 | 10 | -2 | -16.67% | 9 | 1 |
| Dec 31, 2021 | 12 | 2 | 20.00% | 12 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BioCardia | 20 |
| Serina Therapeutics | 13 |
| Genenta Science | 13 |
| Cocrystal Pharma | 11 |
| Cellectar Biosciences | 11 |
| AEON Biopharma | 5 |
| Acurx Pharmaceuticals | 4 |
| Cadrenal Therapeutics | 4 |
PHIO News
- 4 days ago - Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office - Newsfile Corp
- 10 days ago - Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT - GlobeNewsWire
- 10 days ago - Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026, 11 AM EDT - Newsfile Corp
- 15 days ago - Phio Pharmaceuticals Reports 2025 Year-End Financial Results and Business Update - Newsfile Corp
- 15 days ago - Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series - Newsfile Corp
- 5 weeks ago - What's Going On With Tiny Cancer Biotech Phio Pharmaceuticals On Thursday? - Benzinga
- 5 weeks ago - Cancer Biotech Phio Pharmaceuticals Stock Surges As Trial Shows Tumor Clearance At Highest Dose In Skin Cancer Patients - Benzinga
- 5 weeks ago - Phio Announces Safety Monitoring Committee's (SMC) Positive Wrap-up on Lead Clinical Candidate PH-762 in Skin Cancer Trial - Newsfile Corp